BR112014008172A2 - nail health enhancing compositions - Google Patents

nail health enhancing compositions

Info

Publication number
BR112014008172A2
BR112014008172A2 BR112014008172A BR112014008172A BR112014008172A2 BR 112014008172 A2 BR112014008172 A2 BR 112014008172A2 BR 112014008172 A BR112014008172 A BR 112014008172A BR 112014008172 A BR112014008172 A BR 112014008172A BR 112014008172 A2 BR112014008172 A2 BR 112014008172A2
Authority
BR
Brazil
Prior art keywords
nail
compositions
health
effective
cuticle
Prior art date
Application number
BR112014008172A
Other languages
Portuguese (pt)
Inventor
G Walt John
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BR112014008172A2 publication Critical patent/BR112014008172A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists

Abstract

abstract the present invention is directed to compositions and methods for enhancing the health of nails and cuticles in a mammal, including humans. the compositions may be administered topically to the nail bed, nail matrix and cuticle in an amount effective to enhance nail health. the composition is also effective in strengthening and growing nails. ********************* tradução do resumo resumo patente de invenção: "composições para aumento da saúde da unha". a presente invenção refere-se a composições e métodos para aumento da saúde de unhas e cutículas em um mamífero, incluindo humanos. as composições podem ser administradas topicamente ao leito da unha, matriz da unha e cutícula em uma quantidade eficaz para aumentar a saúde da unha. a composição é também eficaz em fortalecimento e crescimento de unhas. 20951703v1 1/1 20951703v1abstract the present invention is directed to compositions and methods for enhancing the health of nails and cuticles in a mammal, including humans. the compositions may be administered topically to the nail bed, nail matrix and cuticle in an effective amount to enhance nail health. The composition is also effective in strengthening and growing nails. ********************* Translation of the abstract patent summary: "compositions for enhancing nail health". The present invention relates to compositions and methods for enhancing nail and cuticle health in a mammal, including humans. The compositions may be administered topically to the nail bed, nail matrix and cuticle in an amount effective to enhance nail health. The composition is also effective in strengthening and growth of nails. 20951703v1 1/1 20951703v1

BR112014008172A 2011-10-05 2012-10-01 nail health enhancing compositions BR112014008172A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161543758P 2011-10-05 2011-10-05
PCT/US2012/058333 WO2013052424A2 (en) 2011-10-05 2012-10-01 Compositions for enhancing nail health

Publications (1)

Publication Number Publication Date
BR112014008172A2 true BR112014008172A2 (en) 2017-04-18

Family

ID=47046873

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014008172A BR112014008172A2 (en) 2011-10-05 2012-10-01 nail health enhancing compositions

Country Status (10)

Country Link
EP (1) EP2763649A2 (en)
JP (1) JP2014528447A (en)
KR (1) KR20140096048A (en)
CN (1) CN103987370A (en)
AR (1) AR088234A1 (en)
AU (1) AU2012318823A1 (en)
BR (1) BR112014008172A2 (en)
CA (1) CA2851346A1 (en)
TW (1) TW201321025A (en)
WO (1) WO2013052424A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104487449A (en) 2012-06-01 2015-04-01 阿勒根公司 Cyclosporin A analogs
US9914755B2 (en) 2015-01-08 2018-03-13 Allergan, Inc. Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65914C (en) 1978-03-07 1984-08-10 Sandoz Ag FRAMEWORK FOR PHARMACEUTICAL COMPOSITION OF CYCLOSPORINE A
US5342625A (en) 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
IL144975A0 (en) 1999-02-26 2002-06-30 Univ British Columbia A composition containing an antisense oligonucleotide
US6254860B1 (en) 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US20060008432A1 (en) * 2004-07-07 2006-01-12 Sebastiano Scarampi Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
EP1958638A1 (en) * 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans to increase nail growth rate
KR20110123739A (en) * 2009-01-08 2011-11-15 알러간, 인코포레이티드 Compositions for enhancing nail growth

Also Published As

Publication number Publication date
CA2851346A1 (en) 2013-04-11
CN103987370A (en) 2014-08-13
WO2013052424A2 (en) 2013-04-11
JP2014528447A (en) 2014-10-27
AU2012318823A1 (en) 2014-04-24
WO2013052424A3 (en) 2013-11-14
EP2763649A2 (en) 2014-08-13
TW201321025A (en) 2013-06-01
KR20140096048A (en) 2014-08-04
AR088234A1 (en) 2014-05-21

Similar Documents

Publication Publication Date Title
BRPI1006826A2 (en) COMPOSITIONS TO IMPROVE NAIL GROWTH
BR112014006220A2 (en) galacto-ramnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic liver fat disease
BRPI0715932A2 (en) hair or hair care compositions which can enhance the appearance of hair or hair by making them thicker and fuller
BR112015001313A2 (en) vaccine compositions
BR112012012476A2 (en) "nutritional compositions including a high protein component and exogenous nucleotides"
BR112014026703A2 (en) dna-pk inhibitors
BR112015014477A2 (en) zinc amino acid / trimethylglycine halide personal cleansing compositions
BR112012023021A2 (en) indazole compounds and their uses
BR112014031394A2 (en) compositions and methods for transmucosal absorption
BR112015024846A2 (en) compositions for use in stimulating bone growth
MX352276B (en) Compositions and methods for improving the appearance of aging hair.
CR20110318A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS TO BE USED IN THE TREATMENT OF METABOLIC DISORDERS
BR112014009097A2 (en) composition for use in promoting healthy bone growth and / or preventing and / or treating bone disease.
EA201491199A1 (en) NANOPARTICLES INCLUDING METAL MATERIAL AND MATERIAL HAFNIUM OXIDE, COMPOSITION AND ITS APPLICATION
BR112013000776A2 (en) Method and Formulation for Treatment of Sialic Acid Deficiency
BR112014003640A2 (en) weight loss methods and ketogenic compositions
BR112014008190A2 (en) nail health enhancement compositions
BR112013020586A2 (en) USE OF UMBILICAL CORD TISSUE DERIVED CELLS
BRPI1015539A2 (en) burn treatment compositions and methods
BR112014012726A2 (en) hair care compositions
BR112012017443A2 (en) use of copolymers, method for enhancing the water resistance of a cosmetic formulation, formulation, and eye, lip or face makeup
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
BR112013026698A2 (en) topical type formulations comprising cyclic depsipeptide
MX2016000294A (en) Pharmaceutical composition for a sustained release of lanreotide.
BR112013017267A8 (en) liposome formulation, suspension and pharmaceutical composition

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)